I'm currently developing a human flow panel for peripheral blood cells. The lymphocyte and monocyte sub-populations (CD4, CD8, CD20, CD14, CD16) look as expected, but although we are getting a very nice yield of granulocytes (determined by FSC/SSC), they're almost all CD66b+ and CD16-, which leads me to believe they've become activated and are beginning to go through apoptosis. As we're running healthy young volunteer samples  I think this high level of activation may be a the result of the protocol itself. Has anyone else experienced this?

Should I use two separate protocols, one for PBMCs and a gentler (and faster) one for the PMNs?

In addition, has anyone had any success with freezing granulocytes and still being able to detect markers by flow cytometry?

Protocol Details: 

All cells undergo erythrocyte lysis in a commercial buffer and fixation in 4% PFA before staining.  The wash buffer contains 2% BSA and is blocked in 10% human serum.

More Meaghan Roy-O'Reilly's questions See All
Similar questions and discussions